Organigram Global (OGI) Earnings Date, Estimates & Call Transcripts $1.37 -0.06 (-4.20%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$1.37 0.00 (-0.07%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Organigram Global Earnings Summary Organigram Global posted Q1 2025 earnings on February 11, 2025, reporting an EPS of -$0.05, which missed the consensus estimate of -$0.03 by $0.02. With a trailing EPS of $0.10 and a P/E Ratio of 13.70, Organigram Global's earnings are expected to grow next year, from ($0.19) to ($0.06) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (Feb. 11) -$0.03 Actual EPS (Feb. 11) -$0.05 Missed By -$0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Slide Deck Press ReleaseOGI Upcoming EarningsOrganigram Global's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Organigram Global Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram Global and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOGI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OGI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Organigram Global Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.04-$0.02-$0.03Q2 20252-$0.03-$0.03-$0.03Q3 20252-$0.01-$0.01-$0.01Q4 20252-$0.01-$0.01-$0.01 FY 2025 8 -$0.09 -$0.07 -$0.08 Q1 20261-$0.01-$0.01-$0.01Q2 20261-$0.01-$0.01-$0.01Q3 20261$0.00$0.00$0.00Q4 20261$0.01$0.01$0.01 Organigram Global Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------2/11/2025Q1 2025-$0.03-$0.05 -$0.02-$0.14$48.94M-12/18/2024Q4 2024-$0.03-$0.04 -$0.01-$0.04--8/13/2024Q3 2024-$0.05$0.02+$0.07$0.02$28.67M$30.01M5/14/2024Q2 2024-$0.06-$0.12 -$0.06-$0.02$28.27M$27.91M2/13/2024Q1 2024-$0.10-$0.14 -$0.04-$0.14$28.61M$26.78M12/19/2023Q4 2023--$0.04 -$0.04--$34.53M7/13/2023Q3 2023-$0.05-$0.15 -$0.10$0.20$31.32M$24.14M Organigram Global Earnings - Frequently Asked Questions When is Organigram Global's earnings date? Organigram Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on OGI's earnings history. Did Organigram Global beat their earnings estimates last quarter? In the previous quarter, Organigram Global (NASDAQ:OGI) missed the analysts' consensus estimate of ($0.03) by $0.02 with a reported earnings per share (EPS) of ($0.05). Learn more on analysts' earnings estimate vs. OGI's actual earnings. How can I listen to Organigram Global's earnings conference call? The conference call for Organigram Global's latest earnings report can be listened to online. Listen to Conference Call How can I read Organigram Global's conference call transcript? The conference call transcript for Organigram Global's latest earnings report can be read online. Read Transcript How much revenue does Organigram Global generate each year? Organigram Global (NASDAQ:OGI) has a recorded annual revenue of $117.47 million. How much profit does Organigram Global generate each year? Organigram Global (NASDAQ:OGI) has a recorded net income of -$33.39 million. OGI has generated $0.10 earnings per share over the last four quarters. What is Organigram Global's price-to-earnings ratio? Organigram Global (NASDAQ:OGI) has a trailing price-to-earnings ratio of 13.70. What is Organigram Global's EPS forecast for next year? Organigram Global's earnings are expected to grow from ($0.19) per share to ($0.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies Iovance Biotherapeutics Earnings Results KalVista Pharmaceuticals Earnings Results Immatics Earnings Results Day One Biopharmaceuticals Earnings Results Sionna Therapeutics Earnings Results ORIC Pharmaceuticals Earnings Results Xeris Biopharma Earnings Results AnaptysBio Earnings Results Xencor Earnings Results Anavex Life Sciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:OGI) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredPresident Trump Could Soon Unlock Trillions in New WealthIf you think America is broke, think again. These "reserve accounts" are worth trillions... And according t...InvestorPlace | SponsoredThe Dollar Reset Nobody’s Talking AboutCould this man take down the financial system? In March, the Senate granted sweeping powers to a Harvard ec...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.